Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **bacterial conjugation machinery in Gram-negative pathogens** is a multiprotein system that mediates horizontal gene transfer via direct cell-to-cell contact, functioning as the primary mechanism by which plasmid DNA—including antibiotic resistance, virulence, and metabolic genes—is disseminated within and between bacterial populations[1][5][3]. This process is universally conserved among Gram-negative bacteria, with the machinery encoded either on conjugative plasmids or integrative conjugative elements. The system comprises key complexes such as the **relaxosome** (responsible for site-specific plasmid DNA cleavage and processing), the **Type IV coupling protein (T4CP, a hexameric ATPase transporter)**, and the **Type IV secretion system (T4SS)** which constructs the conjugative pilus necessary for DNA transfer[3][5][6]. Disruption of this machinery represents a novel and increasingly studied therapeutic approach for controlling the spread of antibiotic resistance, though no clinically approved conjugation inhibitors are available yet[6][8]. The machinery's involvement in infection biology, resistance transmission, and potential for targeting by engineered antimicrobials (e.g., CRISPR-delivery via conjugation) makes it a central focus in infectious disease and antimicrobial resistance research[4][7][2].
Inhibition of ATPase activity in Type IV coupling protein (T4CP) blocks DNA transfer[8][6] Blocking pilus assembly or function prevents cell contact and DNA transport[8] Disrupting relaxosome activity or DNA processing machinery impedes plasmid transfer[3][5]
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial conjugation machinery in Gram-negative pathogen.